Evaluation of the 8th Edition TNM Classification for Anaplastic Thyroid Carcinoma

Background: The tumor−node−metastasis (TNM) classification system to categorized anaplastic thyroid cancer (ATC) was revised. Methods: The revised system was evaluated using a large database of ATC patients. Results: A total of 757 patients were analyzed. The proportion and media...

Full description

Bibliographic Details
Main Authors: Naoyoshi Onoda, Iwao Sugitani, Ken-ichi Ito, Akifumi Suzuki, Takuya Higashiyama, Tatsuya Fukumori, Nobuyasu Suganuma, Katsuhiko Masudo, Hirotaka Nakayama, Atsuhiko Uno, Katsunari Yane, Seiichi Yoshimoto, Aya Ebina, Yukari Kawasaki, Shigeto Maeda, Manabu Iwadate, Shinichi Suzuki
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/12/3/552
id doaj-ea4baba4bf554bb39902f9daa0376e1c
record_format Article
spelling doaj-ea4baba4bf554bb39902f9daa0376e1c2020-11-25T02:55:11ZengMDPI AGCancers2072-66942020-02-0112355210.3390/cancers12030552cancers12030552Evaluation of the 8th Edition TNM Classification for Anaplastic Thyroid CarcinomaNaoyoshi Onoda0Iwao Sugitani1Ken-ichi Ito2Akifumi Suzuki3Takuya Higashiyama4Tatsuya Fukumori5Nobuyasu Suganuma6Katsuhiko Masudo7Hirotaka Nakayama8Atsuhiko Uno9Katsunari Yane10Seiichi Yoshimoto11Aya Ebina12Yukari Kawasaki13Shigeto Maeda14Manabu Iwadate15Shinichi Suzuki16Anaplastic Thyroid Carcinoma Research Consortium of Japan, Tokyo 113-8603, JapanAnaplastic Thyroid Carcinoma Research Consortium of Japan, Tokyo 113-8603, JapanAnaplastic Thyroid Carcinoma Research Consortium of Japan, Tokyo 113-8603, JapanAnaplastic Thyroid Carcinoma Research Consortium of Japan, Tokyo 113-8603, JapanAnaplastic Thyroid Carcinoma Research Consortium of Japan, Tokyo 113-8603, JapanAnaplastic Thyroid Carcinoma Research Consortium of Japan, Tokyo 113-8603, JapanAnaplastic Thyroid Carcinoma Research Consortium of Japan, Tokyo 113-8603, JapanAnaplastic Thyroid Carcinoma Research Consortium of Japan, Tokyo 113-8603, JapanAnaplastic Thyroid Carcinoma Research Consortium of Japan, Tokyo 113-8603, JapanAnaplastic Thyroid Carcinoma Research Consortium of Japan, Tokyo 113-8603, JapanAnaplastic Thyroid Carcinoma Research Consortium of Japan, Tokyo 113-8603, JapanAnaplastic Thyroid Carcinoma Research Consortium of Japan, Tokyo 113-8603, JapanAnaplastic Thyroid Carcinoma Research Consortium of Japan, Tokyo 113-8603, JapanAnaplastic Thyroid Carcinoma Research Consortium of Japan, Tokyo 113-8603, JapanAnaplastic Thyroid Carcinoma Research Consortium of Japan, Tokyo 113-8603, JapanAnaplastic Thyroid Carcinoma Research Consortium of Japan, Tokyo 113-8603, JapanAnaplastic Thyroid Carcinoma Research Consortium of Japan, Tokyo 113-8603, JapanBackground: The tumor&#8722;node&#8722;metastasis (TNM) classification system to categorized anaplastic thyroid cancer (ATC) was revised. Methods: The revised system was evaluated using a large database of ATC patients. Results: A total of 757 patients were analyzed. The proportion and median overall survival values (OS: months) for each T category were T1 (<i>n</i><i> </i>= 8, 1.1%, 12.5), T2 (<i>n</i> = 43, 5.7%, 10.9), T3a (<i>n</i> = 117, 15.5%, 5.7), T3b (<i>n</i> = 438, 57.9%, 3.9), and T4 (<i>n</i> = 151, 19.9%, 5.0). The OS of the N0 and N1 patients were 5.9 and 4.3, respectively (log-rank <i>p</i> &lt; 0.01). Sixty-three (58.3%) patients migrated from stage IV&#8201;A to IV&#8201;B by revision based on the existence of nodal involvement and 422 patients (55.7%) were stratified into stage IV&#8201;B, without a worsening of their OS (6.1), leaving 45 patients (5.9%) in stage IV A with fair OS (15.8). The hazard ratios for the survival of the patients of stage IV&#8201;B compared to stage IV&#8201;A increased from 1.1 to 2.1 by the revision. No change was made for stage IV C (<i>n</i> = 290, 38.8%, 2.8). Conclusion: The revised TNM system clearly indicated the prognoses of ATC patients by extracting rare patients with fair prognoses as having stage IV&#8201;A disease and categorized many heterogeneous patients in stage IV&#8201;B.https://www.mdpi.com/2072-6694/12/3/552anaplastic thyroid cancerprognosisdisease stagetnm classificationprognostic index
collection DOAJ
language English
format Article
sources DOAJ
author Naoyoshi Onoda
Iwao Sugitani
Ken-ichi Ito
Akifumi Suzuki
Takuya Higashiyama
Tatsuya Fukumori
Nobuyasu Suganuma
Katsuhiko Masudo
Hirotaka Nakayama
Atsuhiko Uno
Katsunari Yane
Seiichi Yoshimoto
Aya Ebina
Yukari Kawasaki
Shigeto Maeda
Manabu Iwadate
Shinichi Suzuki
spellingShingle Naoyoshi Onoda
Iwao Sugitani
Ken-ichi Ito
Akifumi Suzuki
Takuya Higashiyama
Tatsuya Fukumori
Nobuyasu Suganuma
Katsuhiko Masudo
Hirotaka Nakayama
Atsuhiko Uno
Katsunari Yane
Seiichi Yoshimoto
Aya Ebina
Yukari Kawasaki
Shigeto Maeda
Manabu Iwadate
Shinichi Suzuki
Evaluation of the 8th Edition TNM Classification for Anaplastic Thyroid Carcinoma
Cancers
anaplastic thyroid cancer
prognosis
disease stage
tnm classification
prognostic index
author_facet Naoyoshi Onoda
Iwao Sugitani
Ken-ichi Ito
Akifumi Suzuki
Takuya Higashiyama
Tatsuya Fukumori
Nobuyasu Suganuma
Katsuhiko Masudo
Hirotaka Nakayama
Atsuhiko Uno
Katsunari Yane
Seiichi Yoshimoto
Aya Ebina
Yukari Kawasaki
Shigeto Maeda
Manabu Iwadate
Shinichi Suzuki
author_sort Naoyoshi Onoda
title Evaluation of the 8th Edition TNM Classification for Anaplastic Thyroid Carcinoma
title_short Evaluation of the 8th Edition TNM Classification for Anaplastic Thyroid Carcinoma
title_full Evaluation of the 8th Edition TNM Classification for Anaplastic Thyroid Carcinoma
title_fullStr Evaluation of the 8th Edition TNM Classification for Anaplastic Thyroid Carcinoma
title_full_unstemmed Evaluation of the 8th Edition TNM Classification for Anaplastic Thyroid Carcinoma
title_sort evaluation of the 8th edition tnm classification for anaplastic thyroid carcinoma
publisher MDPI AG
series Cancers
issn 2072-6694
publishDate 2020-02-01
description Background: The tumor&#8722;node&#8722;metastasis (TNM) classification system to categorized anaplastic thyroid cancer (ATC) was revised. Methods: The revised system was evaluated using a large database of ATC patients. Results: A total of 757 patients were analyzed. The proportion and median overall survival values (OS: months) for each T category were T1 (<i>n</i><i> </i>= 8, 1.1%, 12.5), T2 (<i>n</i> = 43, 5.7%, 10.9), T3a (<i>n</i> = 117, 15.5%, 5.7), T3b (<i>n</i> = 438, 57.9%, 3.9), and T4 (<i>n</i> = 151, 19.9%, 5.0). The OS of the N0 and N1 patients were 5.9 and 4.3, respectively (log-rank <i>p</i> &lt; 0.01). Sixty-three (58.3%) patients migrated from stage IV&#8201;A to IV&#8201;B by revision based on the existence of nodal involvement and 422 patients (55.7%) were stratified into stage IV&#8201;B, without a worsening of their OS (6.1), leaving 45 patients (5.9%) in stage IV A with fair OS (15.8). The hazard ratios for the survival of the patients of stage IV&#8201;B compared to stage IV&#8201;A increased from 1.1 to 2.1 by the revision. No change was made for stage IV C (<i>n</i> = 290, 38.8%, 2.8). Conclusion: The revised TNM system clearly indicated the prognoses of ATC patients by extracting rare patients with fair prognoses as having stage IV&#8201;A disease and categorized many heterogeneous patients in stage IV&#8201;B.
topic anaplastic thyroid cancer
prognosis
disease stage
tnm classification
prognostic index
url https://www.mdpi.com/2072-6694/12/3/552
work_keys_str_mv AT naoyoshionoda evaluationofthe8theditiontnmclassificationforanaplasticthyroidcarcinoma
AT iwaosugitani evaluationofthe8theditiontnmclassificationforanaplasticthyroidcarcinoma
AT kenichiito evaluationofthe8theditiontnmclassificationforanaplasticthyroidcarcinoma
AT akifumisuzuki evaluationofthe8theditiontnmclassificationforanaplasticthyroidcarcinoma
AT takuyahigashiyama evaluationofthe8theditiontnmclassificationforanaplasticthyroidcarcinoma
AT tatsuyafukumori evaluationofthe8theditiontnmclassificationforanaplasticthyroidcarcinoma
AT nobuyasusuganuma evaluationofthe8theditiontnmclassificationforanaplasticthyroidcarcinoma
AT katsuhikomasudo evaluationofthe8theditiontnmclassificationforanaplasticthyroidcarcinoma
AT hirotakanakayama evaluationofthe8theditiontnmclassificationforanaplasticthyroidcarcinoma
AT atsuhikouno evaluationofthe8theditiontnmclassificationforanaplasticthyroidcarcinoma
AT katsunariyane evaluationofthe8theditiontnmclassificationforanaplasticthyroidcarcinoma
AT seiichiyoshimoto evaluationofthe8theditiontnmclassificationforanaplasticthyroidcarcinoma
AT ayaebina evaluationofthe8theditiontnmclassificationforanaplasticthyroidcarcinoma
AT yukarikawasaki evaluationofthe8theditiontnmclassificationforanaplasticthyroidcarcinoma
AT shigetomaeda evaluationofthe8theditiontnmclassificationforanaplasticthyroidcarcinoma
AT manabuiwadate evaluationofthe8theditiontnmclassificationforanaplasticthyroidcarcinoma
AT shinichisuzuki evaluationofthe8theditiontnmclassificationforanaplasticthyroidcarcinoma
_version_ 1724717780658290688